Implementation of a Pharma Company’s Publication Policy that Ensures Compliance in an Increasingly Scrutinized Environment

Time

Wed, Jun 27 11:00AM
W 17

Title

Implementation of a Pharma Company’s Publication Policy that Ensures Compliance in an Increasingly Scrutinized Environment

Abstract Summary

In 2006, a US steering committee was formed to develop publication IGs addressing 1) adherence to ICMJE authorship guidelines, 2) disclosure of company support, 3) no payments to investigators for development of primary publications, 4) no marketing involvement, 5) author access to trial data.

Poster Presenter

Michelle Kissner
PharmD, RPh,
Director, Publications Management,
Pfizer Inc.
United States

© 2015 DIA